Sign in
Enrolling by invitationNo phase

Tracks heart and lung changes over time using ultrasound and AI

Observes whether ultrasound and AI can spot worsening in adults with heart conditions.

Key facts

Who runs it
Truway Health, Inc.
Where
New York, United StatesSee the site
Trial code
Registry title
Multimodal Physiologic State Intelligence Study
Status
Enrolling by invitation
People taking part
25,000 people, planned
Started
2 Sept 2026
Expected to end
15 Sept 2046
Type of study
Observational
Treatments tested
  • OMNIPHYS Multimodal Ultrasound Imaging System
Record updated
10 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who are having routine heart, blood vessel, lung, kidney or other medical care. Healthy volunteers can also join as reference participants.

Age
18 years or older
Sex
All sexes can join

Main reasons for not taking part

  • Cannot give informed consent or meet the consent requirements
  • Scans or measurements the study needs cannot be read clearly
  • The study investigator judges that taking part is not appropriate
  • Cannot be followed over time in a meaningful way
  • Withdrew consent

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Adults aged 18 years or older who are capable of providing informed consent, or who meet applicable legally authorized representative requirements where permitted
  • Individuals undergoing routine clinical evaluation, diagnostic imaging, monitoring, treatment, or longitudinal follow-up, including individuals with relevant cardiovascular, vascular, pulmonary, renal, systemic, or other conditions represented within the OMNIPHYS research framework
  • Healthy volunteers without the conditions under study may participate as reference participants
  • Ability to undergo at least one protocol-relevant physiologic or imaging assessment and/or contribute eligible routinely collected clinical data
  • Availability of sufficient clinical, physiologic, imaging, or longitudinal outcome data for the applicable analysis
  • Willingness to permit collection and longitudinal analysis of protocol-defined research data in accordance with informed consent and applicable privacy and data-governance requirements

Who cannot take part

  • Conditions or circumstances that, in the judgment of the responsible clinical investigator, make participation inappropriate or prevent meaningful longitudinal follow-up
  • Inability or unwillingness to provide informed consent or otherwise meet applicable consent requirements
  • Inability to obtain interpretable protocol-relevant physiologic or imaging data when such data are required for the applicable analysis
  • Withdrawal of consent or request for discontinuation of research participation where applicable
  • Any circumstance that would prevent collection, secure handling, or analysis of study data in accordance with the approved protocol and applicable requirements

Where in United States

  • Truway Health, Inc.New York, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The OMNIPHYS study will investigate whether multimodal ultrasound and other routinely collected clinical and physiologic data can be combined with artificial intelligence to characterize changes in a person's physiologic state over time. The study will examine cardiac, vascular, pulmonary, and systemic physiologic measurements and develop longitudinal models that describe baseline physiology, physiologic perturbation, compensation, deterioration, treatment response, and recovery. The study is observational and will not assign experimental treatments. The goal is to determine whether changes in multimodal physiologic patterns can be identified and characterized earlier and more reliably than conventional single-time-point assessment.

The group in the trial

  • OMNIPHYS Master Physiologic Cohort

    A prospective longitudinal observational cohort of participants undergoing routine clinical evaluation and/or care. The cohort will be characterized using multimodal physiologic observations, including ultrasound-derived imaging, 2D and 3D imaging, color and spectral Doppler, cardiac and vascular measurements, pulmonary ultrasound findings, vital signs, ECG, oxygen saturation, laboratory data, medications, diagnoses, clinical encounters, and longitudinal outcomes. Participants will not be assigned to an experimental treatment. Disease-specific and physiologic subcohorts may be evaluated within the master cohort using a common longitudinal physiologic-state framework.

    Treatment: OMNIPHYS Multimodal Ultrasound Imaging System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration
Plain-language title
Tracks heart and lung changes over time using ultrasound and AIGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
10 September 2026